Cart
sales@molnova.com
UCCF-853
CAS No. 625458-06-2
UCCF-853( —— )
Catalog No. M34455 CAS No. 625458-06-2
UCCF-853 is a small-molecule CFTR modulator that can be used to study cystic fibrosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | Get Quote |
|
| 5MG | 69 | Get Quote |
|
| 10MG | 107 | Get Quote |
|
| 25MG | 174 | Get Quote |
|
| 50MG | 260 | Get Quote |
|
| 100MG | 377 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameUCCF-853
-
NoteResearch use only, not for human use.
-
Brief DescriptionUCCF-853 is a small-molecule CFTR modulator that can be used to study cystic fibrosis.
-
DescriptionUCCF-853 is a CFTR modulator.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetCFTR
-
RecptorCFTR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number625458-06-2
-
Formula Weight312.67
-
Molecular FormulaC14H8ClF3N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC2=CC(=CC=C2N1C=3C=CC=C(Cl)C3)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nicoletta Pedemonte, et al. Influence of cell background on pharmacological rescue of mutant CFTR. Am J Physiol Cell Physiol. 2010 Apr;298(4):C866-74.?
molnova catalog
related products
-
CFTR corrector 4
CFTR corrector 4 is a potent and orally available transmembrane conductance regulator (CFTR) for cystic fibrosis and is a potent (R,R) type active enantiomer.
-
BPO-27 racemate
BPO-27 is a potent, metabolically stable CFTR inhibitor (IC50= 8 nM).
-
(R)-BPO-27
(R)-BPO-27, the R enantiomer of BPO-27, CFTR chloride conductance with IC50 of 4 nM; BPO-27 S enantiomer is inactive.
